Cite
APA Citation
Schmidt, L., Kuemmel, A., Schliemann, C., Schulze, A., Humberg, J., Mohr, M., Görlich, D., Hartmann, W., Bröckling, S., Marra, A., Hillejan, L., Goletz, S., Karsten, U., Berdel, W., Spieker, T., & Wiewrodt, R. (2016). blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC. Lung cancer, 92, 8–14. http://access.bl.uk/ark:/81055/vdc_100031001539.0x000003